Meeting Details

The 45th Annual General Meeting of the Members of Emcure Pharmaceuticals Limited was held on Monday, September 21, 2026, at 11:00 a.m. (IST). The meeting was conducted entirely through Video Conferencing (VC)/Other Audio Visual Means (OAVM) facility, without the physical presence of Members at a common venue, in compliance with the Companies Act, 2013 and relevant circulars from the Ministry of Corporate Affairs and SEBI. The meeting commenced at 11:00 a.m. and concluded at 12:23 p.m. (IST), which included time allowed for e-voting during the AGM. The deemed venue was the Registered Office of the Company at Plot No. P-1 & P2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Pune – 411 057, Maharashtra.

Summary of Proposed Resolutions

The following eight resolutions, as per the Notice of the 45th AGM, were transacted:

Ordinary Business:

1. To receive, consider, and adopt the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026, along with the Reports of the Board of Directors and the Auditors.

2. To declare a Final Dividend of INR 3.60 (Rupees Three and Sixty Paise only) per Equity Share of face value INR 10 each for the financial year ended March 31, 2026.

3. To re-appoint Mrs. Namita Thapar (DIN: 05318899), a Director who retires by rotation.

4. To consider the retirement of Mr. Berjis Desai (DIN: 00153675), Chairman and Non-Executive Non-Independent Director.

Special Business:

5. To ratify the remuneration payable to the Cost Auditor, M/s. B.M. Sharma & Co., for the financial year 2026-27.

6. To re-appoint Dr. Mukund Gurjar (DIN: 00026843) as a Whole-time Director of the Company.

7. To re-appoint Mr. Satish Mehta (DIN: 00118691) as a Managing Director & Chief Executive Officer of the Company.

8. To appoint Mr. Raghu Kumar (DIN: 01983106) as an Independent Director of the Company.

The Chairman noted that there were no qualifications in the Statutory Auditor's Report or the Secretarial Audit Report.

Voting Process

  • The company availed the facility of MUFG Intime India Private Limited for e-voting and VC participation.
  • The remote e-voting facility was open from Friday, September 18, 2026, to Sunday, September 20, 2026.
  • An electronic voting facility during the AGM was made available for Members who had not voted via remote e-voting. This facility remained open for thirty minutes post the conclusion of the meeting.
  • Mrs. Ashwini Inamdar, Partner of M/s. Mehta & Mehta, Company Secretaries, Mumbai, was appointed as the Scrutinizer to supervise the entire e-voting process and scrutinize the votes cast.
  • As the meeting was held virtually, the provisions for appointing proxies were not applicable.

Key Voting Outcomes

The detailed results of the voting on the resolutions are not provided in this document. The Company Secretary & Compliance Officer was authorized to receive the scrutinizer's report, declare the results, and upload them on the company's website and stock exchanges within the statutory timeline.

Scrutinizer's Role

Mrs. Ashwini Inamdar was the appointed Scrutinizer. Her role was to supervise the e-voting process and scrutinize all votes cast, both remotely and during the meeting. Her report was to be received after the meeting.

Compliance Confirmation

The document confirms that the meeting was convened and held in compliance with the provisions of the Companies Act, 2013, the SEBI (LODR) Regulations, 2015, and relevant circulars issued by the Ministry of Corporate Affairs and SEBI.

Attendees and Signatories

Board Members and KMPs in Attendance:

  • Mr. Satish Mehta (Managing Director & CEO)
  • Mr. Berjis Desai (Chairman)
  • Mr. Sunil Mehta (Whole-time Director & CSR Committee Chairman)
  • Mrs. Namita Thapar (Whole-time Director)
  • Mr. Samit Mehta (Whole-time Director & COO)
  • Dr. Mukund Gurjar (Whole-time Director)
  • Mr. C S Muralidharan (Independent Director & Audit Committee Chairman)
  • Dr. Shailesh Ayyangar (Independent Director & Risk Management Committee Chairman)
  • Mr. Vijay Gokhale (Independent Director & Nomination and Remuneration Committee Chairman)
  • Mr. Raghu Kumar (Independent Director)
  • Mr. Tajuddin Shaikh (Chief Financial Officer)
  • Ms. Amruta Yangalwar (Company Secretary & Compliance Officer)

Apologies for Absence:

  • Dr. Vidya Yeravdekar (Woman Independent Director)

Representatives Present:

  • Authorized representatives of M/s. BSR & Co. LLP (Statutory Auditors)
  • Authorized representatives of M/s. B.M. Sharma & Co. (Cost Auditors)
  • Authorized representatives of M/s. SVD & Associates (Secretarial Auditors)
  • Mrs. Ashwini Inamdar (Scrutinizer)

The letter is digitally signed by Amruta Amit Yangalwar, Company Secretary & Compliance Officer (ICSI Membership Number: A25687), on behalf of Emcure Pharmaceuticals Limited.